Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18676 - 18700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	LMBR1	64327	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LMBR1 mRNA	7q36.3	A21749
Copper	Approved Investigational	LMCD1	29995	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LMCD1 mRNA	3p25.3	A21750
Copper	Approved Investigational	LMNB1	4001	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LMNB1 mRNA	5q23.2	A21749
Copper	Approved Investigational	LMNB2	84823	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LMNB2 mRNA	19p13.3	A21749
Copper	Approved Investigational	LMTK2	22853	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LMTK2 mRNA	7q21.3	A21750
Copper	Approved Investigational	LOR	4014	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LOR mRNA	1q21.3	A21750
Copper	Approved Investigational	LPAR6	10161	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LPAR6 mRNA	13q14.2	A21749
Copper	Approved Investigational	LPP	4026	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LPP mRNA	3q27.3-q28	A21749
Copper	Approved Investigational	LPXN	9404	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LPXN mRNA	11q12.1	A21749
Copper	Approved Investigational	LRIG3	121227	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LRIG3 mRNA	12q14.1	A21749
Copper	Approved Investigational	LRP8	7804	upregulated	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA	1p32.3	A21750
Copper	Approved Investigational	LRP8	7804	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LRP8 mRNA	1p32.3	A21749
Copper	Approved Investigational	LRRC20	55222	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LRRC20 mRNA	10q22.1	A21749
Copper	Approved Investigational	LRRC34	151827	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LRRC34 mRNA	3q26.2	A21749
Copper	Approved Investigational	LRRC45	201255	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LRRC45 mRNA	17q25.3	A21749
Copper	Approved Investigational	LRRC49	54839	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LRRC49 mRNA	15q23	A21749
Copper	Approved Investigational	LSMEM1	286006	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LSMEM1 mRNA	7q31.1	A21750
Copper	Approved Investigational	LSS	4047	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LSS mRNA	21q22.3	A21749
Copper	Approved Investigational	LTB4R	1241	upregulated	[Disulfiram binds to Copper] which results in increased expression of LTB4R mRNA	14q12	A21750
Copper	Approved Investigational	LTBP2	4053	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LTBP2 mRNA	14q24.3	A21749
Copper	Approved Investigational	LURAP1L	286343	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LURAP1L mRNA	9p23	A21749
Copper	Approved Investigational	LY6E	4061	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LY6E mRNA	8q24.3	A21749
Copper	Approved Investigational	LY96	23643	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA	8q21.11	A21749
Copper	Approved Investigational	LYAR	55646	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LYAR mRNA	4p16.3	A21749
Copper	Approved Investigational	LYSMD3	116068	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LYSMD3 mRNA	5q14.3	A21749

Displaying entries 18676 - 18700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability